Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 10Gastrointestinal 9Genitourinary 6Thoracic 5CNS 4Tumor-Agnostic 3Lymphoid 3Other hematologic neoplasm 2Endocrine 2Other neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Pituitary Neoplasms 2

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6Nivolumab 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Propofol × Endocrine × Clear all
NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

Peking Union Medical College Hospital

Phase 4 Completed
252 enrolled
Endocrine

Pituitary Neoplasms

NCT05088252 2023-06-22

Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection

Beijing Tiantan Hospital

Phase NA Completed
112 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡